tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Irina Rivkind Koffler, 14 are a BUY (48.28%), 9 are a HOLD (31.03%), 6 are a SELL (20.69%).
Analyst Irina Rivkind Koffler, currently employed at LIFESCI, carries an average stock price target met ratio of 65.12% that have a potential upside of 22.96% achieved within 212 days.
Irina Rivkind Koffler’s has documented 514 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MNK, Mallinckrodt plc at 06-Aug-2019.
Analyst best performing recommendations are on DRRX (DURECT).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS) at 1/9/2017. The price target of $64 was fulfilled within 2 days with a profit of $4.1 (6.02%) receiving and performance score of 30.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$3.99 (395.05%)
$6
7 months 21 days ago
(01-Apr-2024)
1/5 (20%)
$3.89 (350.45%)
34
Buy
1 years 3 months 12 days ago
(10-Aug-2023)
0/2 (0%)
$27.7 (101.47%)
Buy
1 years 3 months 12 days ago
(10-Aug-2023)
0/1 (0%)
$42.3 (238.98%)
Buy
$27
$24.51 (984.34%)
$32
1 years 3 months 12 days ago
(10-Aug-2023)
0/2 (0%)
$25.57 (661.71%)
Buy
$80
$78.99 (7820.79%)
3 years 6 months 17 days ago
(05-May-2021)
1/4 (25%)
$62.3 (351.98%)
343
What Year was the first public recommendation made by Irina Rivkind Koffler?
